Burger line Burger line Burger line
Logo Logo Logo
Burger line Burger line Burger line
Menu
Advanced
Wish Lists Wish Lists
Wish Lists Wish Lists
Wish Lists
Cart Cart
Cart Cart
Cart
Sign in
Sign in
For suppliers Contact us
Advanced
Homepage > Company > Media > Pharma News > 2017 > Teva introduces generic Trilafon

Teva introduces generic Trilafon

NORTH WALES, Penn. — Teva has launched its generic of Trilafon (perphenazine) tablets. The drug is indicated to treat schizophrenia and to control severe nausea and vomiting in adults.

ChemSpider 2D Image | Perphenazine | C21H26ClN3OS

“Our customers count on Teva for a continuous supply of new generic products,” Teva COO North American generics Maureen Cavanaugh said. “With the launch of perphenazine tablets, we add another quality product to our broad line of affordable generic pharmaceuticals.”

Teva’s generic is available in 2-, 4-, 8- and 16-mg dosage strengths.

http://www.drugstorenews.com/

Read also

FDA warns vs fake versions of popular medicines
FDA warns vs fake versions of popular medicines
MANILA, Philippines - counterfeit versions of some popular over-the-counter pain relievers and flu medicines are circulating in the market, the Food and Drug Administration (FDA) reported. ...
Japan's Eisai inks $2 B oncology deal with China-based startup Bliss Biopharma
Japan's Eisai inks $2 B oncology deal with China-based startup Bliss Biopharma
Cognixion, a developer of non-invasive Brain-Computer Interface (BCI) and Augmented Reality (AR) technology, has announced that the US Food and Drug Administration (FDA) has granted its device Brea...
Cognixion receives FDA Breakthrough Device Designation for assisted communication device
Cognixion receives FDA Breakthrough Device Designation for assisted communication device
Cognixion, a developer of non-invasive Brain-Computer Interface (BCI) and Augmented Reality (AR) technology, has announced that the US Food and Drug Administration (FDA) has granted its device Brea...
EMA to review CTIS transparency rules
EMA to review CTIS transparency rules
Public consultation seeks the best methods for balancing transparency with confidentiality in the EU Clinical Trials Information System, says the European Medicines Agency. ...
0 items in Cart
Cart Subtotal:
Go to cart
You will be able to Pay Online or Request a Quote
Catalog
Services
Company
Catalog of Screening Compounds
Screening Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom chemistry. Chemistry FTE. Resynthesis.
Medicinal chemistry FTE
In silico drug design (CADD)
Discovery Biology. Biology FTE. In vitro studies.
Animal models
Toxicology and safety
ADME, DMPK. In vivo studies
Chemistry, manufacturing and controls
Company
News & Media
Contact us
For suppliers

Trends in discovery compounds

We use "cookies*  to ensure the functionality of our website, recognise your browser or device, learn more about your interests, and provide you with essential features and services and for additional purposes, including:

Recognising you when you sign-in to use our services. This allows us to provide you with product recommendations, display personalised content, and provide other customised features and services.
Keeping track of your specified preferences. You may set your preferences through Your Account..
Keeping track of items stored in your shopping basket and personal cabinet.
Conducting research and diagnostics to improve ChemDiv’s content, products, and services.
Delivering content, including ads, relevant to your interests on ChemDiv’s site
Reporting. This allows us to measure and analyse the performance of our services.

By  cookies you give consent to the processing of your personal data, including transfer to third parties. Further information can be found in our privacy policy.

Accept all cookies